[Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices]               
[Page 64676]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-136]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 26, 2007, and published in the Federal 
Register on July 5, 2007, (72 FR 36729), Cambrex Charles City, Inc., 
1205 11th Street, Charles City, Iowa 50616, made application by letter 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Morphine (9300), a basic class of controlled substance 
listed in schedule II.
    The company plans to manufacture the listed controlled substance 
for sale as an intermediate to generic drug customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex Charles City, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Cambrex Charles City, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-22517 Filed 11-15-07; 8:45 am]

BILLING CODE 4410-09-P